SOURCE: Lpath, Inc.

Lpath, Inc.

August 14, 2009 08:35 ET

Lpath to Present at the Southern California Investor Conference

SAN DIEGO, CA--(Marketwire - August 14, 2009) - Lpath, Inc. (OTCBB: LPTN), the category leader in therapeutic agents against bioactive lipids, will present at the 14th Annual Southern California Investor Conference being held on August 18, 2009 at the Island Hotel in Newport Beach, California.

The conference is hosted by California Equity Research and highlights the abundance of growth companies located in the region, including world-recognized life science, technology, media, and real estate/financial companies.

Lpath President and CEO Scott R. Pancoast is scheduled to present on Tuesday, August 18 at 9:30 a.m. Pacific time (12:30 p.m. Eastern time), followed by a break-out session and one-on-one meetings. The presentation will be available via webcast at

For more information on the Southern California Investor Conference, please visit the conference website at or call the conference desk at (858) 829-8688.

About Lpath

San Diego-based Lpath, Inc. is the category leader in lipidomics-based therapeutics, an emerging field of medicine that targets bioactive signaling lipids for treating a wide range of human disease. Lpath's ImmuneY2™ drug-discovery engine has the unique ability to generate therapeutic antibodies that bind to and inhibit bioactive lipids that contribute to disease. The company is currently advancing three drug candidates, two of which -- ASONEP™ for cancer and iSONEP™ for AMD -- are in late-Phase 1 clinical trials, For ASONEP, Lpath has joined with international drug giant Merck-Serono under a worldwide exclusive license and development partnership. For more information, go to

Contact Information